Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Prostate cancer has become the most common cancer in men in the UK. One in eight men will develop the condition at some point in their lives, with more than 47,000 new cases being diagnosed every year.

© John Cairns

Professor Ian Mills, from the Nuffield Department of Surgical Sciences, first began researching prostate cancer in 2003. 'I'm a molecular biologist, so my entry point to the disease was a protein called the androgen receptor,' explains the John Black Associate Professor of Prostate Cancer. Androgen receptors work by binding to testosterone and steroid hormones, which are both regulators of prostate development and prostate progression in men.

In the years that followed, the genomics revolution has made it possible for researchers to map this process in unprecedented detail. The findings have had a significant impact upon the development of targeted hormone treatments, and much work is now being undertaken to increase their efficacy – often by combining clinically proven drugs with other forms of treatment, such as radiation or immunotherapy.

Read more (Oxford Thinking Campaign website)

Similar stories

Genetic mapping of tumours reveals how cancers grow

Researchers from the University of Oxford, KTH Royal Institute of Technology, Science for Life Laboratory, and the Karolinska Institutet, Solna, Sweden, have found that individual prostate tumours contain a previously unknown range of genetic variation.

Two NDS researchers receive prestigious MRC Clinical Research Training Fellowships

Miss Catherine Lovegrove and Dr Alexander Sagar from the Nuffield Department of Surgical Sciences (NDS) have been awarded highly competitive Clinical Research Training Fellowships by the Medical Research Council (MRC).

WHO Classification of Tumours programme awarded large grant to improve classification and evidence base

A new project titled Mapping the Evidence for the World Health Organization (WHO) Classification of Tumours: A Living Evidence Gap Map by Tumour Type (WCT EVI MAP), led by researchers of the WHO Classification of Tumours programme at the International Agency for Research on Cancer (IARC), has received a grant of €3.5 million from the European Commission. This four-year project, which will be undertaken in collaboration with six other international institutions, including Oxford University's Nuffield Department of Surgical Sciences (NDS), was launched on 1 July 2022.

Blog posts

Oxford MedSci goes silver: 10 Years of Athena SWAN

The Medical Sciences Division is celebrating 10 years since its first Athena Swan bronze application, and the first year in which all 16 of its departments have achieved a silver award. The silver award recognises commitment to gender equality, understanding culture and context, and more. Read about our department’s hard work and innovation.

Lights, camera, action! My journey into video production

Dr Hannah McGivern provides a 'behind-the-scenes' account of her experience producing the video 'Journey of a QUOD Sample: Donating to Transplant Research', supported by the funds from the University of Oxford Public Engagement with Research (PER) Seed Fund.

Mentoring in practice

NDS has launched a new, interdepartmental mentoring scheme called RECOGNISE. In this podcast, Gemma Horbatowski (HR Advisor) interviews Monica Dolton (Programme Manager and Research Project Manager) about her experiences of mentor-mentee relationships.